Leukemia Therapeutics 2020 Trends, Market Share, Industry Size, Opportunities, Analysis And Forecast To 2028

0
0

A new market study, titled “Leukemia Therapeutics Forecast 2021-2028” has been featured on Fortune Business Insights™.

 

***Get Latest Updated Market Research Report with Free Sample Report

Market Overview

The global leukemia therapeutics market size is projected to reach USD 27.78 billion by 2027, exhibiting a CAGR of 8.1% during the forecast period. The increasing demand for enhanced treatments for blood cancers amid the COVID-19 pandemic will accelerate the market, states Fortune Business Insights™ in its report, titled “Leukemia Therapeutics Market Size, Share & Industry Analysis, By Type of Leukemia (Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), and Others), By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Route of Administration (Oral Mode and Injectable Mode), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2027”.

Request for Free Sample Report PDF @ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/leukemia-therapeutics-market-104754  

Cancer patients are at a heightened risk of contracting the coronavirus and likely to experience severe effects of the infection due to their weakened immune systems. According to a study conducted by the UK Coronavirus Cancer Monitoring Project (UKCCMP), patients with leukemia, multiple myeloma, and lymphoma are highly susceptible to COVID-19 and leukemia patients have twice the chance of dying from the virus. The study found that patients with blood cancer are 57% more likely to experience severe symptoms of COVID-19 than patients with other types of cancers. Given these and other similar findings, the demand for leukemia therapeutics has been soaring during the COVID-19 pandemic, with market players reporting increased sales. Bristol-Myers Squibb, for instance, announced that the sales of Sprycel, its treatment for chronic myeloid leukemia (CML) jumped 14% to USD 521 million in the first quarter of 2020. However, the disruption in the medical supply chain will lead the market to register a lower growth rate of 6.2% and touch a value of USD 16.15 billion in 2020.

As per the report findings, the estimated value of the global market stood at USD 15.21 billion in 2019. The main highlights of the report include:

  • Calculated estimations about the upcoming trends and prospects in the market;
  • Path-breaking research into the regional dynamics of the market;
  • Comprehensive study of the factors driving and restraining the market; and
  • Careful profiling and diagnosis of the key market players and their dominant strategies.

Restraining Factors

Debilitating Side Effects of Chemotherapy May Hinder Market Growth

Chemotherapy is one of the most potent leukemia therapeutics and has emerged as the most powerful and the most commonly recommended treatment for most types of cancers. Chemo drugs are designed to attack and kill fast-growing cells, and since cancer cells proliferate rapidly, these medications speedily eliminate them. However, because chemo medicines travel throughout the body, they end up killing healthy cells, leading to side effects that can considerably weaken the patient, albeit temporarily. For example, chemotherapy can harm the blood cells in the bone marrow, where red blood cells (RBCs) are manufactured. With RBC production disrupted, the patient is likely to experience moderate to severe anemia, which in turn can cause symptoms such as fatigue, lightheadedness, and general weakness. Furthermore, chemo can also harm the production of white blood cells (WBCs), the body’s soldiers that fight infections. As a result, cancer patients become extremely susceptible to infections and even a minor bout of cough & cold can prove detrimental for them. Thus, the known side effects of chemotherapy may hamper the leukemia therapeutics market growth.   

Regional Insights

North America to Foster Stable Market Growth Backed by High Healthcare Expenditure

North America is expected to dominate the leukemia therapeutics market share during the forecast period as the USA and Canada have sharply increased their spending on healthcare technologies and infrastructure in the past few decades. Moreover, policymakers in the two countries are taking constant efforts to expand healthcare coverage, especially for cancer patients. In 2019, the region’s market size stood at USD 6.92 billion.

Europe is poised to emerge as the second-largest market for leukemia therapeutics due to the increasing number of leukemia patients in the continent. In the UK, for instance, leukemia accounted for 3% of all cancer cases in the country in 2017, according to Cancer Research UK. The market in Asia Pacific, on the other hand, will experience prolific growth owing to the improving health reimbursement policies in China and India.

Competitive Landscape

Regulatory Support for Innovative Therapies to Raise Market Potential

Key players in this market are enjoying a period of consistent support for their offerings by regulatory bodies such as the US Food and Drug Administration (FDA). Such support will play an instrumental role in managing leukemia symptoms in patients and the criticality of leukemia therapeutics is likely to rise as cancer prevalence grows worldwide.

Industry Developments:

  • October 2020: The US FDA cleared AbbVie’s VENCLEXTA treatment in combination with azacitidine, or decitabine, or low-dose cytarabine. The therapy is indicated for treating acute myeloid leukemia (AML) in adults aged 75 years and above or those with comorbidities who cannot undergo intensive chemotherapy.
  • September 2020: Bristol Myers Squibb secured the US FDA’s approval for its Onuregfor the continued treatment of adult patients with AML. The treatment is designed for those patients who have attained the first complete remission or remission with incomplete blood recovery following intensive chemo.

Ask for Customization @ https://www.fortunebusinessinsights.com/enquiry/customization/leukemia-therapeutics-market-104754   

List of Key Companies Covered in the Leukemia Therapeutics Market Report:

  • Sanofi/ Genzyme Corporation (Paris, France)
  • Hoffmann-La Roche (Basel, Switzerland)
  • Johnson & Johnson Services, Inc. (New Brunswick, U.S.)
  • Amgen Inc. (Thousand Oaks, U.S.)
  • Novartis (Basel, Switzerland)
  • Takeda Pharmaceutical Co Ltd (Tokyo, Japan)
  • Bristol-Myers Squibb (New York, U.S.)
  • AbbVie (North Chicago, U.S.)
  • Lupin Ltd. (India, Mumbai)
  • Pfizer Inc. (New York, U.S.)

 

Table Of Content:

  1. Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Key Insights
    • Pipeline Analysis, Key Players
    • Prevalence of Leukemia, Key Countries, 2019
    • Key Industry Developments (Mergers, Acquisition, etc.)
    • Impact of Covid-19 on the Leukemia Therapeutics Market
  5. Global Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type of Leukemia
      • Chronic Myeloid Leukemia (CML)
      • Chronic Lymphocytic Leukemia (CLL)
      • Acute Lymphocytic Leukemia (ALL)
      • Acute Myeloid Leukemia (AML)
      • Others
    • Market Analysis, Insights and Forecast – By Treatment Type
      • Chemotherapy
      • Targeted Therapy
      • Immunotherapy
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Injectable Mode
      • Oral Mode
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa
  1. North America Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Type of Leukemia
      • Chronic Myeloid Leukemia (CML)
      • Chronic Lymphocytic Leukemia (CLL)
      • Acute Lymphocytic Leukemia (ALL)
      • Acute Myeloid Leukemia (AML)
      • Others
    • Market Analysis – By Treatment Type
      • Chemotherapy
      • Targeted Therapy
      • Immunotherapy
      • Others
    • Market Analysis – By Route of Administration
      • Injectable Mode
      • Oral Mode
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Market Analysis – By Country
      • S.
      • Canada
  1. Europe Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Type of Leukemia
      • Chronic Myeloid Leukemia (CML)
      • Chronic Lymphocytic Leukemia (CLL)
      • Acute Lymphocytic Leukemia (ALL)
      • Acute Myeloid Leukemia (AML)
      • Others
    • Market Analysis – By Treatment Type
      • Chemotherapy
      • Targeted Therapy
      • Immunotherapy
      • Others
    • Market Analysis – By Route of Administration
      • Injectable Mode
      • Oral Mode
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Market Analysis – By Country/Sub-Region
      • K.
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
  1. Asia Pacific Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Type of Leukemia
      • Chronic Myeloid Leukemia (CML)
      • Chronic Lymphocytic Leukemia (CLL)
      • Acute Lymphocytic Leukemia (ALL)
      • Acute Myeloid Leukemia (AML)
      • Others
    • Market Analysis – By Treatment Type
      • Chemotherapy
      • Targeted Therapy
      • Immunotherapy
      • Others
    • Market Analysis – By Route of Administration
      • Injectable Mode
      • Oral Mode
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Market Analysis – By Country/Sub-Region
      • Japan
      • China
      • India
      • Australia
      • Rest of Asia Pacific
  1. Latin America Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Type of Leukemia
      • Chronic Myeloid Leukemia (CML)
      • Chronic Lymphocytic Leukemia (CLL)
      • Acute Lymphocytic Leukemia (ALL)
      • Acute Myeloid Leukemia (AML)
      • Others
    • Market Analysis – By Treatment Type
      • Chemotherapy
      • Targeted Therapy
      • Immunotherapy
      • Others
    • Market Analysis – By Route of Administration
      • Injectable Mode
      • Oral Mode
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Market Analysis – By Country/Sub-Region
      • Brazil
      • Mexico
      • Rest of Latin America
  1. Middle East & Africa Leukemia Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis – By Type of Leukemia
      • Chronic Myeloid Leukemia (CML)
      • Chronic Lymphocytic Leukemia (CLL)
      • Acute Lymphocytic Leukemia (ALL)
      • Acute Myeloid Leukemia (AML)
      • Others
    • Market Analysis – By Treatment Type
      • Chemotherapy
      • Targeted Therapy
      • Immunotherapy
      • Others
    • Market Analysis – By Route of Administration
      • Injectable Mode
      • Oral Mode
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Market Analysis – By Country/Sub-Region
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
  1. Competitive Analysis
    • Key Industry Developments
    • Global Market Share Analysis (2019)
    • Competition Dashboard
    • Comparative Analysis – Major Players
    • Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
      • Pfizer Inc.
      • Novartis
      • Sanofi/ Genzyme Corporation
      • Lupin Ltd.
      • Amgen Inc.
      • AbbVie
      • Johnson & Johnson Services, Inc.
      • Bristol-Myers Squibb
      • Hoffmann-La Roche
      • Takeda Pharmaceutical Co Ltd
      • Sanofi/ Genzyme Corporation

                                                               

Continued. . .

Related Article @

https://marketresearchreportsfbi.wordpress.com/2021/11/08/autotransfusion-devices-market-by-technology-share-size-segmentation-revenue-analysis-forecast-2028/ 

https://www.theexpresswire.com/pressrelease/US-C-arms-Market-to-Reach-11461-Million-With-CAGR-44-During-Forecast-2021-2028_14682333  

https://www.marketwatch.com/press-release/infectious-disease-point-of-care-poc-diagnostics-projection-by-technology-top-key-players-growth-revenue-cagr-regional-analysis-industry-forecast-2028–2021-12-03

https://www.marketwatch.com/press-release/dermatology-drugs-projection-by-technology-share-size-trend-demand-growth-sales-revenue-regional-analysis-industry-forecast-2028–2021-12-03

https://www.marketwatch.com/press-release/global-asia-scoliosis-management-projection-by-key-players-share-size-trends-segmentation-regional-analysis-industry-growth-forecast-2028-2021-12-03

https://www.marketwatch.com/press-release/global-point-of-care-ultrasound-research-report-by-investment-in-the-medical-industry-opportunity-and-strategies-forecast-2028-2021-12-03

NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

LinkedIn: https://www.linkedin.com/company/fortune-business-insights

Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd

Twitter: https://twitter.com/FBInsightPvtLtd

 

Showing 0 results
Your Answer

Please first to submit.

Get involved

Register

As a member of this site you will be able to receive aggregates news relating only to those categories that are most relevant to you, submit job listings for FREE, post questions in the Q&A, and more.

Register Now

Feature your company

The Feature Your Company listing is your custom-made (by us) profile page that allows you to add any of the following content: text, videos, links, images. The page will also be listed on the Featured Company landing page. Over 560 unique aggregates users visit the site per day! Complete the enquiry form now to contact us.

Contact us

Jobs

Are you looking for an aggregate related job? Click here to see our jobs listing supplied by industry experts United Employment.

See Jobs

Advertise

Reach thousands of budget holders and decision makers by promoting your company on the longest established aggregate website in the US & Canada. Or advertise in our emails which are sent to opted-in subscribers according to their chosen categories. All advertising will display correctly on tablets and mobiles as this site is responsive.